jeudi 27 novembre 2014

CCGs poised to defy pharma by switching to cheaper, unlicensed drug

CCGs poised to defy pharma by switching to cheaper, unlicensed drug

Clinical commissioning groups across England are mulling the use of an unlicensed drug which could save the NHS millions of pounds, HSJ has learned

Aucun commentaire:

Enregistrer un commentaire